deltatrials
Active Not Recruiting OBSERVATIONAL NCT03193528

A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer

Sponsor: Cedars-Sinai Medical Center

Conditions Bladder Cancer
Updated 20 times since 2017 Last updated: Feb 2, 2026 Started: Dec 30, 2016 Primary completion: Jul 31, 2026 Completion: Jul 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Bladder Cancer, this trial is ongoing. The trial is conducted by Cedars-Sinai Medical Center and has accumulated 20 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Apr 2020 · 22 months · monthly snapshot~Apr 2020 – ~Nov 2020 · 7 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~May 2021 · 4 months · monthly snapshot~May 2021 – ~Oct 2021 · 5 months · monthly snapshot~Oct 2021 – ~Dec 2021 · 2 months · monthly snapshot~Dec 2021 – ~Apr 2022 · 4 months · monthly snapshot~Apr 2022 – ~May 2022 · 30 days · monthly snapshot~May 2022 – ~Apr 2023 · 11 months · monthly snapshot~Apr 2023 – ~Jun 2023 · 2 months · monthly snapshot~Jun 2023 – ~Nov 2023 · 5 months · monthly snapshot~Nov 2023 – ~May 2024 · 6 months · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshot~Jun 2025 – ~Feb 2026 · 8 months · monthly snapshot~Feb 2026 – present · 7 months · monthly snapshot

Change History

20 versions recorded

  1. Feb 2026 — Present [monthly]

    Active Not Recruiting

    Status: Recruiting → Active Not Recruiting

  2. Jun 2025 — Feb 2026 [monthly]

    Recruiting

  3. Sep 2024 — Jun 2025 [monthly]

    Recruiting

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  5. May 2024 — Jul 2024 [monthly]

    Recruiting

▶ Show 15 earlier versions

  1. Nov 2023 — May 2024 [monthly]

    Recruiting

  2. Jun 2023 — Nov 2023 [monthly]

    Recruiting

  3. Apr 2023 — Jun 2023 [monthly]

    Recruiting

  4. May 2022 — Apr 2023 [monthly]

    Recruiting

  5. Apr 2022 — May 2022 [monthly]

    Recruiting

  6. Dec 2021 — Apr 2022 [monthly]

    Recruiting

  7. Oct 2021 — Dec 2021 [monthly]

    Recruiting

  8. May 2021 — Oct 2021 [monthly]

    Recruiting

  9. Jan 2021 — May 2021 [monthly]

    Recruiting

  10. Nov 2020 — Jan 2021 [monthly]

    Recruiting

  11. Apr 2020 — Nov 2020 [monthly]

    Recruiting

  12. Jun 2018 — Apr 2020 [monthly]

    Recruiting

  13. May 2018 — Jun 2018 [monthly]

    Recruiting

  14. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NA → None

  15. Aug 2017 — Apr 2018 [monthly]

    Recruiting NA

    First recorded

Dec 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cedars-Sinai Medical Center
  • Fred Hutchinson Cancer Center
  • Nara Medical University
  • Nara Prefecture Seiwa Medical Center
  • National Cancer Institute (NCI)
  • Nonagen Bioscience Corporation
  • University of California, Los Angeles
  • University of Rochester
  • University of Texas
Data source: Cedars-Sinai Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations